Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment-Reference-Cited by-同舟云学术

Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment

Published:2017-02-27 Issue:3 Volume:69 Page:506-517
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Fleischmann Roy¹,Schiff Michael²,van der Heijde Désirée³,Ramos-Remus Cesar⁴,Spindler Alberto⁵,Stanislav Marina⁶,Zerbini Cristiano A. F.⁷,Gurbuz Sirel⁸,Dickson Christina⁸,de Bono Stephanie⁸,Schlichting Douglas⁸,Beattie Scott⁸,Kuo Wen-Ling⁸,Rooney Terence⁸,Macias William⁸,Takeuchi Tsutomu⁹

Affiliation:

1. Metroplex Clinical Research Center; Dallas Texas

2. University of Colorado; Denver

3. Leiden University Medical Center, Leiden, The Netherlands, and Imaging Rheumatology BV; Meerssen The Netherlands

4. Unidad de Investigacion en Enfermedades Cronico-Degenerativas; Guadalajara Mexico

5. Centro Medico Privado de Reumatologia; Tucuman Argentina

6. Scientific Research Institute of Rheumatology, Russian Academy of Medical Sciences; Moscow Russia

7. Centro Paulista de Investigação Clinica; São Paulo Brazil

8. Eli Lilly and Company; Indianapolis Indiana

9. Keio University School of Medicine; Tokyo Japan

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.39953/fullpdf

Reference27 articles.

1. Current understanding of rheumatoid arthritis therapy;Colmegna;Clin Pharmacol Ther,2012

2. Therapeutic strategies for rheumatoid arthritis;Smolen;Nat Rev Drug Discov,2003

3. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative;Aletaha;Arthritis Rheum,2010

4. Frequency of methotrexate intolerance in rheumatoid arthritis patients using methotrexate intolerance severity score (MISS questionnaire);Fatimah;Clin Rheumatol,2016

5. Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort;Nikiphorou;Clin Rheumatol,2014

Cited by 331 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JAK inhibitor selectivity: new opportunities, better drugs?;Nature Reviews Rheumatology;2024-09-09

2. Real-world study comparing the efficacy of Janus kinase inhibitors in patients with difficult-to-treat rheumatoid arthritis;Clinical Rheumatology;2024-09-07

3. Baricitinib: key results of long-term use in rheumatoid arthritis;Modern Rheumatology Journal;2024-08-21

4. Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance study;Modern Rheumatology;2024-08-09

5. Cumulative incidence and risk of infection in patients with rheumatoid arthritis treated with janus kinase inhibitors: A systematic review and meta-analysis;PLOS ONE;2024-07-31